DCGI approves use of Covaxin for children age between 6 to 12 years

Tags: National Science and Technology

The Drugs Controller General of India (DCGI) has given approval (EUA) to the corona vaccine 'Covexin' for children in the age group of 6-12 years.

• Covexin has been developed by Hyderabad-based Bharat Biotech.

• DCGI has also approved Corbevax for emergency use for people between the ages of 5 to 12.

• DCGI also approves ZycovD for children above 12 years of age.

• About Drug Controller General of India (DCGI)

• It is responsible for the approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines and sera in India.

• It also establishes standards for the manufacture, sale, import and distribution of drugs in India.

• It works under the Ministry of Health and Family Welfare.